Subscribe To Our Free Newsletter |
Sun Pharma settles patent litigation with Actavis; ends 1.2% higher
Ranbaxy Pharmaceuticals Inc., a unit of Sun Pharmaceutical Industries, has settled a patent litigation with Actavis over the generic version of Absorica, a drug used to treat acne.